Get started
Author

Manuela Robella

Observed names: M Robella, M. Robella, MANUELA ROBELLA
ORCID: 0000-0001-7676-9658
Observed ORCID: 0000-0001-7676-9658
OpenAlex ID: A5017714141
Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis
2016 · Manuela Robella, Marco Vaira, et al. · World Journal of Surgical Oncology · 139
PDF
10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis
2023 · Andrea Di Giorgio, Antonio Macrì, et al. · Cancers · 94
Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)
2022 · Olivia Sgarbura, Clarisse Eveno, et al. · Pleura and Peritoneum · 54
PDF
Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification?
2020 · Olivia Sgarbura, Laurent Villeneuve, et al. · European Journal of Surgical Oncology · 50
PDF
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial
2020 · Michele De Simone, Marco Vaira, et al. · Biomedicines · 49
PDF
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis
2021 · Manuela Robella, Michele De Simone, et al. · Cancers · 40
PDF
Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: Technical aspects and treatment protocols
2021 · Martin Hübner, Mohammad Alyami, et al. · European Journal of Surgical Oncology · 38
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry
2017 · RENAPE Working Group, Konstantinos I. Votanopoulos, et al. · Annals of Surgical Oncology · 37
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
2021 · Marco Tonello, Dario Baratti, et al. · Annals of Surgical Oncology · 36
PDF
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
2018 · Eleonora Ghisoni, Dionyssios Katsaros, et al. · Journal of Ovarian Research · 36
PDF
Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)
2020 · R. Lo Dico, M. Faron, et al. · European Journal of Surgical Oncology · 34
PDF
Implementation of an enhanced recovery after surgery protocol for colorectal cancer in a regional hospital network supported by audit and feedback: a stepped wedge, cluster randomised trial
2024 · Eva Pagano, Luca Pellegrino, et al. · BMJ Quality & Safety · 33
PDF
Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
2023 · Enrico Maria Pasqual, Ambrogio P. Londero, et al. · Cancers · 33
PDF
Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO)
2023 · Marco Vaira, Manuela Robella, et al. · Cancers · 29
PDF
Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma
2023 · Shigeki Kusamura, Dario Baratti, et al. · Cancers · 26
PDF
Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis
2023 · Manuela Robella, Marco Tonello, et al. · Cancers · 26
PDF
Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence
2014 · Marco Vaira, Manuela Robella, et al. · International Journal of Hyperthermia · 24
PDF
Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis
2022 · Fabio Carboni, Mario Valle, et al. · Cancers · 23
PDF
Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
2014 · M Robella, M Vaira, et al. · PubMed · 22
Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx®) as Pressurized Intraperitoneal Aerosol Chemotherapy
2019 · Manuela Robella, Marco Vaira, et al. · Frontiers in Pharmacology · 20
PDF
Contamination risk for operators performing semi-closed HIPEC procedure using cisplatin
2014 · A. Caneparo, P. Massucco, et al. · European Journal of Surgical Oncology · 20
Feasibility and safety of PIPAC combined with additional surgical procedures: PLUS study
2022 · Manuela Robella, Martin Hubner, et al. · European Journal of Surgical Oncology · 19
PDF
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes
2019 · Manuela Robella, Marco Vaira, et al. · Minerva Chirurgica · 18
PIPAC nebulizer: How to test the new devices in the market, expert recommendations
2022 · M. Pocard, J.B.Y. So, et al. · Journal of Visceral Surgery · 16
PDF
Single-port access for Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): technique, feasibility and safety
2016 · Marco Vaira, Manuela Robella, et al. · Pleura and Peritoneum · 16
Works count: 81
Citation count: 1,109
H-index: 20
I10-index: 31
Year
Topic
Type